CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX
Wenting Jia(Central South University), Weidong Liu(National University of Defense Technology), Bin Zhu(Capital Medical University), Weihong Tan(Petronas (Malaysia)), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Menghui Gao(Central South University), Yuxiang Chen(Institute of Deep-Sea Science and Engineering), Shasha Li(Green Chemistry), Xiaobing Zhang(Hunan University), Liang Zeng(Central South University), Caiping Ren(Central South University), Lei Wang(Central South University), Ting Fu(Salk Institute for Biological Studies), Can Du(Central South University), Xiaomeng Xia(Central South University), Fei Zeng(University of Electronic Science and Technology of China), Xingjun Jiang(Central South University)
Cited by 59
Related Papers
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
|Analytical Chemistry|2001|748
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
Preparation and antibacterial activity of Fe<sub>3</sub>O<sub>4</sub>@Ag nanoparticles
|Nanotechnology|2007|600
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585